Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 10, 2025Archiv EuromedicaOpen Access

Efficacy of systemic glucocorticoids in pediatric Mycoplasma pneumoniae infection

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMikołaj SzewczykowskiTKTomasz KlinkoszEOEwa Otręba

Discussion

Loading...

Member takes

Overview

This review evaluates glucocorticoids' impact on severe Mycoplasma pneumoniae pneumonia in children, indicating potential benefits.

Key Points

  • Combination therapy with glucocorticoids and antibiotics improves clinical outcomes in pediatric pneumonia.
  • Early administration of glucocorticoids within 24–36 hours links to better outcomes in children with severe infections.
  • Intravenous methylprednisolone is commonly used, showing no significant increase in adverse events.
  • Evidence limitations include small sample sizes and regional concentration of studies, suggesting a need for diverse trials.

Cite This Study

Szewczykowski et al. (2025) studied this question.

synapsesocial.com/papers/68c23b4ab210217d6478440chttps://doi.org/10.35630/2025/15/4.003
View Full Paper
Ask AI
Bookmark
Share